| Q42059608 | A catalytically and genetically optimized beta-lactamase-matrix based assay for sensitive, specific, and higher throughput analysis of native henipavirus entry characteristics |
| Q39213391 | A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner. |
| Q63246151 | A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike |
| Q56535662 | Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus |
| Q30437911 | Alpha5beta1-integrin controls ebolavirus entry by regulating endosomal cathepsins |
| Q33624624 | An enzymatic virus-like particle assay for sensitive detection of virus entry |
| Q30946649 | Anthrax toxin uptake by primary immune cells as determined with a lethal factor-beta-lactamase fusion protein |
| Q62383594 | Antiviral Agents Against Ebola Virus Infection: Repositioning Old Drugs and Finding Novel Small Molecules |
| Q36326038 | Antiviral activity of a Rac GEF inhibitor characterized with a sensitive HIV/SIV fusion assay |
| Q38790676 | Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions |
| Q40094400 | Arenavirus entry occurs through a cholesterol-dependent, non-caveolar, clathrin-mediated endocytic mechanism |
| Q24296677 | Bicaudal D1-dependent trafficking of human cytomegalovirus tegument protein pp150 in virus-infected cells |
| Q34901977 | Biodefense Oriented Genomic-Based Pathogen Classification Systems: Challenges and Opportunities |
| Q30434699 | Cell adhesion-dependent membrane trafficking of a binding partner for the ebolavirus glycoprotein is a determinant of viral entry |
| Q37839350 | Cell entry of enveloped viruses. |
| Q36553687 | Cell-cell contact promotes Ebola virus GP-mediated infection |
| Q36567284 | Cellular factors implicated in filovirus entry |
| Q38802500 | Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection |
| Q34251147 | Cytoplasmic Body Component TRIM5α Requires Lipid-enriched Microdomains for Efficient HIV-1 Restriction |
| Q39107540 | Defective HIV-1 quasispecies in the form of multiply drug-resistant proviral DNA within cells can be rescued by superinfection with different subtype variants of HIV-1 and by HIV-2 and SIV. |
| Q35914471 | Dendritic cells infected with vpr-positive human immunodeficiency virus type 1 induce CD8+ T-cell apoptosis via upregulation of tumor necrosis factor alpha. |
| Q34593045 | Determination of specific antibody responses to the six species of ebola and Marburg viruses by multiplexed protein microarrays |
| Q38546746 | Development of Small-Molecule Antivirals for Ebola |
| Q36379341 | Development of treatment strategies to combat Ebola and Marburg viruses |
| Q35533766 | Differential requirements for clathrin endocytic pathway components in cellular entry by Ebola and Marburg glycoprotein pseudovirions |
| Q33785133 | Discovery, synthesis, and biological evaluation of a novel group of selective inhibitors of filoviral entry |
| Q35173023 | Distinct requirements for HIV-cell fusion and HIV-mediated cell-cell fusion. |
| Q35842390 | Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection |
| Q38388679 | Ebola virus disease: societal challenges and new treatments |
| Q35299912 | Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis |
| Q36759731 | Ebola virus exploits a monocyte differentiation program to promote its entry |
| Q24301618 | Ebola virus uses clathrin-mediated endocytosis as an entry pathway |
| Q30243938 | Ebola virus: A gap in drug design and discovery - experimental and computational perspective |
| Q27682816 | Ebolavirus entry requires a compact hydrophobic fist at the tip of the fusion loop |
| Q27313378 | Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner |
| Q36482783 | Endocytic pathways involved in filovirus entry: advances, implications and future directions. |
| Q38785688 | Enhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein. |
| Q38921402 | Equine infectious anemia virus entry occurs through clathrin-mediated endocytosis |
| Q24568225 | FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection. |
| Q40132236 | Filovirus Strategies to Escape Antiviral Responses |
| Q38123988 | Filovirus entry |
| Q35878069 | Filovirus entry into cells - new insights |
| Q37999360 | Filovirus entry: a novelty in the viral fusion world |
| Q38599899 | Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus |
| Q36446078 | Generation of biologically contained Ebola viruses |
| Q26824979 | HIV entry: a game of hide-and-fuse? |
| Q42013191 | HIV-1 Fusion Assay |
| Q39234351 | High content image based analysis identifies cell cycle inhibitors as regulators of Ebola virus infection |
| Q37163676 | Human Survivors of Disease Outbreaks Caused by Ebola or Marburg Virus Exhibit Cross-Reactive and Long-Lived Antibody Responses |
| Q34353507 | Human immunodeficiency virus fusion to dendritic cells declines as cells mature. |
| Q35050840 | Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs |
| Q33733844 | Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus |
| Q30662148 | Imaging real-time HIV-1 virion fusion with FRET-based biosensors |
| Q35299756 | Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles. |
| Q35678774 | Improving attrition rates in Ebola virus drug discovery |
| Q47559131 | In vitro methods for testing antiviral drugs |
| Q64359299 | Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses |
| Q39528697 | Infection of primary neurons mediated by nipah virus envelope proteins: role of host target cells in antiviral action |
| Q27488371 | Initiation of Hepatitis C Virus Infection Requires the Dynamic Microtubule Network: ROLE OF THE VIRAL NUCLEOCAPSID PROTEIN |
| Q45391082 | Involvement of cytoskeleton in Junín virus entry |
| Q47117332 | Lamp1 Increases the Efficiency of Lassa Virus Infection by Promoting Fusion in Less Acidic Endosomal Compartments |
| Q21090770 | Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors |
| Q34517833 | Library screening and receptor-directed targeting of gammaretroviral vectors |
| Q36946651 | Lipids as modulators of membrane fusion mediated by viral fusion proteins |
| Q36585516 | Measuring HIV fusion mediated by envelopes from primary viral isolates |
| Q33797915 | Measuring the strength of interaction between the Ebola fusion peptide and lipid rafts: implications for membrane fusion and virus infection |
| Q40399389 | Microtubule-dependent and microtubule-independent steps in Crimean-Congo hemorrhagic fever virus replication cycle |
| Q28486226 | Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection |
| Q35103126 | Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells |
| Q33628817 | PPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infection |
| Q25255532 | Packaging of actin into Ebola virus VLPs |
| Q60921849 | Persistence and Sexual Transmission of Filoviruses |
| Q59350906 | Perspectives towards antiviral drug discovery against Ebola virus |
| Q27486638 | Phosphoinositide-3 Kinase-Akt Pathway Controls Cellular Entry of Ebola Virus |
| Q28731583 | Rapid screening for entry inhibitors of highly pathogenic viruses under low-level biocontainment |
| Q45338668 | Rapid titration of retroviral vectors using a β-lactamase protein fragment complementation assay |
| Q36469011 | Retrovirus entry by endocytosis and cathepsin proteases |
| Q37355990 | Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors |
| Q36397378 | Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis |
| Q27481481 | Role of Endocytosis and Low pH in Murine Hepatitis Virus Strain A59 Cell Entry |
| Q37602125 | Selective inhibition of Ebola entry with selective estrogen receptor modulators by disrupting the endolysosomal calcium |
| Q33415278 | Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy. |
| Q37873318 | Strategies for in vivo imaging of enzyme activity: an overview and recent advances |
| Q40040589 | Structure of the Ebola virus envelope protein MPER/TM domain and its interaction with the fusion loop explains their fusion activity |
| Q116166892 | Synchronization Temperature Determines the Location of RSV Fusion During Entry in Cultured Cells |
| Q45405891 | TNF-alpha, produced by feline infectious peritonitis virus (FIPV)-infected macrophages, upregulates expression of type II FIPV receptor feline aminopeptidase N in feline macrophages |
| Q35226192 | The Ebola virus glycoprotein mediates entry via a non-classical dynamin-dependent macropinocytic pathway |
| Q30277079 | The Roles of Histidines and Charged Residues as Potential Triggers of a Conformational Change in the Fusion Loop of Ebola Virus Glycoprotein |
| Q24305409 | The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus |
| Q30438367 | The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding |
| Q35823426 | The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge |
| Q26747003 | The β-Lactamase Assay: Harnessing a FRET Biosensor to Analyse Viral Fusion Mechanisms |
| Q36392210 | Viral interactions with the cytoskeleton: a hitchhiker's guide to the cell |
| Q28649882 | Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection |